TAVR Referral & Use: Predicting Mortality

Share on FacebookTweet about this on TwitterShare on LinkedIn

Patients with severe symptomatic aortic stenosis who go untreated following referrals for transcatheter aortic valve replacement (TAVR) appear to have a 1-year mortality rate of almost 40%, according to a study. Among this patient population, those with advanced heart failure, renal dysfunction, low albumin levels, and/or left ventricular dysfunction were at increased risk for mortality.

Source: American Journal of Cardiology, September 15, 2015.

Submit a Comment

Your email address will not be published. Required fields are marked *

20 − sixteen =